The Healthy and At-Risk Populations Program currently has 26 members, 12 of whom are new to the cancer center. The new members include a number of senior and junior recruits to UCLA, as well as previously unaffiliated UCLA faculty members. A new senior level recruit is Lenore Arab, Ph.D., whose focus is on nutrition and cancer. The JCCC provided critical support for Dr. Arab's research. In addition, we were fortunate that the School of Nursing recently recruited Felicia Hodge, Dr.PH, who is also Director, Center for American Indian/Indigenous Research and Education (CAIRE) on the UCLA campus. Dr. Hodge has a long history of tobacco control and cancer screening research in native American populations and has been an excellent addition to HARP. Also in the past funding cycle, Robert Kaplan, Ph.D., was recruited to be the Chair of Health Services in the School of Public Health, and he has joined HARP. Dr. Kaplan is an internationally renowned scholar in the areas of health services and health psychology and conducts research in broad content areas including tobacco control, cancer screening, quality of life, and quality of care. Other internal senior level faculty who have been attracted to join HARP during the past funding cycle include Lillian Gelberg, M.D., Family Medicine and Leeka Kheifets, Ph.D., Epidemiology. Junior faculty recruited to UCLA during the past cycle who have newly joined the cancer center include Michael Ong, M.D., Ph.D., General Internal Medicine-Health Services and Dominic Frosch, Ph.D., General Internal Medicine-Health Services Research. The Program is extremely dynamic, and is viewed as a welcoming and supportive environment for collaborative research. Our members have national and international reputations, and we have in our program three members of the Institute of Medicine. The total number of publications in the last cycle was 425 out of which 18% were inter-programmatic and 18% were intra-programmatic indicating a high level of collaborative research in the program. Fourteen percent of the publications could be characterized as high impact. During the current funding year, peerreviewed funding totaled $11.4 million in total costs, including $5.3 million from the National Cancer Institute. As with other Program Areas, JCCC fosters a number of interactive activities and many of the Shared Resources that support investigators in the HARP Program Area. During the current grant cycle, funds from the JCCC in the form of CCSG Developmental Funds, institutional support and philanthropic gifts to the HARP Program Area total $348,500. These funds supported Seed Grants, the annual Helene Brown award and trainees. Four of the Program Area Members were the recipients of JCCC support.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016042-38
Application #
8392128
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2012-12-01
Budget End
2013-11-30
Support Year
38
Fiscal Year
2013
Total Cost
$142,225
Indirect Cost
$66,161
Name
University of California Los Angeles
Department
Type
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Yu, Jingyi; Seldin, Marcus M; Fu, Kai et al. (2018) Topological Arrangement of Cardiac Fibroblasts Regulates Cellular Plasticity. Circ Res 123:73-85
Hong, Aayoung; Moriceau, Gatien; Sun, Lu et al. (2018) Exploiting Drug Addiction Mechanisms to Select against MAPKi-Resistant Melanoma. Cancer Discov 8:74-93
Epeldegui, Marta; Magpantay, Larry; Guo, Yu et al. (2018) A prospective study of serum microbial translocation biomarkers and risk of AIDS-related non-Hodgkin lymphoma. AIDS 32:945-954
Hsu, Jeffrey J; Lu, Jinxiu; Umar, Soban et al. (2018) Effects of teriparatide on morphology of aortic calcification in aged hyperlipidemic mice. Am J Physiol Heart Circ Physiol 314:H1203-H1213
Woo, Jin Seok; Srikanth, Sonal; Kim, Kyun-Do et al. (2018) CRACR2A-Mediated TCR Signaling Promotes Local Effector Th1 and Th17 Responses. J Immunol 201:1174-1185
Patananan, Alexander N; Sercel, Alexander J; Teitell, Michael A (2018) More than a powerplant: the influence of mitochondrial transfer on the epigenome. Curr Opin Physiol 3:16-24
Heard, Jeffrey J; Phung, Ivy; Potes, Mark I et al. (2018) An oncogenic mutant of RHEB, RHEB Y35N, exhibits an altered interaction with BRAF resulting in cancer transformation. BMC Cancer 18:69
Kim, Roy Y; Mangu, Darian; Hoffman, Alexandria S et al. (2018) Oestrogen receptor β ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis. Brain 141:132-147
Pothoulakis, Charalabos; Torre-Rojas, Monica; Duran-Padilla, Marco A et al. (2018) CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis. Int J Cancer 142:334-346
Montecino-Rodriguez, Encarnacion; Casero, David; Fice, Michael et al. (2018) Differential Expression of PU.1 and Key T Lineage Transcription Factors Distinguishes Fetal and Adult T Cell Development. J Immunol 200:2046-2056

Showing the most recent 10 out of 767 publications